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Abstract: Cationic peptides with antimicrobial properties are ubiquitous in nature and have been
studied for many years in an attempt to design novel antibiotics. However, very few molecules
are used in the clinic so far, sometimes due to their complexity but, mostly, as a consequence
of the unfavorable pharmacokinetic profile associated with peptides. The aim of this work is
to investigate cationic peptides in order to identify common structural features which could be
useful for the design of small peptides or peptido-mimetics with improved drug-like properties
and activity against Gram negative bacteria. Two sets of cationic peptides (AMPs) with known
antimicrobial activity have been investigated. The first reference set comprised molecules with
experimentally-known conformations available in the protein databank (PDB), and the second one
was composed of short peptides active against Gram negative bacteria but with no significant
structural information available. The predicted structures of the peptides from the first set
were in excellent agreement with those experimentally-observed, which allowed analysis of
the structural features of the second group using computationally-derived conformations. The peptide
conformations, either experimentally available or predicted, were clustered in an “all vs. all”
fashion and the most populated clusters were then analyzed. It was confirmed that these
peptides tend to assume an amphipathic conformation regardless of the environment. It was also
observed that positively-charged amino acid residues can often be found next to aromatic residues.
Finally, a protocol was evaluated for the investigation of the behavior of short cationic peptides
in the presence of a membrane-like environment such as dodecylphosphocholine (DPC) micelles.
The results presented herein introduce a promising approach to inform the design of novel short
peptides with a potential antimicrobial activity.
Keywords: cationic antimicrobial peptides (AMPs); amphipathic conformation; molecular dynamics;
protein structure prediction; dodecylphosphocholine (DPC) micelles
1. Introduction
The surge of multidrug resistant microorganisms and the lack of new antibiotics present a major
challenge to modern medicine [1]. Naturally-occurring cationic peptides often possess antimicrobial
properties [2] and represent a promising class of lead compounds to be selected for the design of
new antibiotics. However, of the nearly 5000 cationic antimicrobial peptides (AMPs) described to
date, fewer than 100 are currently undergoing clinical trials [3], possibly due to the challenges related
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to the development of protein-based drugs. Several resources are available for predicting the 3D
conformations of peptides, such as the online software PEP-FOLD [4], as well as their antimicrobial
potential [5]. Three pathways are usually followed in efforts to obtain novel peptides: modification of
existing templates through bioinformatics methods, often looking at the modification of the primary
sequences; biophysical modelling, such as molecular dynamics simulations, which can also take
into account the effect of the environment on the conformations; and screening of libraries which
may focus on the structure activity relationship (SAR) [6,7]. However, the complexity of problems
associated with in vivo application of these molecules and understanding their mechanism of action
calls for a continuous improvement of these methods, with the aim to obtain antimicrobial agents with
improved pharmacological profiles.
Despite their mechanism(s) of action still not being fully understood, it is broadly accepted that
AMP play a role in the alteration of the bacterial membrane and wall systems, with the consequent
disruption of the proton motive force and the general viability of the organism [8]. Although
the experimental studies, such as NMR spectroscopy, can provide information on the structures
and orientation of peptides bound to micelles, in silico studies such as molecular dynamics (MD)
are often utilized for the study of the interaction of AMPs with membrane-like structures [9]. Such
approaches are important for the design of the novel peptides as the hypothesis can be tested before
time-consuming and resource-demanding synthesis and purification.
Therefore, the aim of our work was to investigate both the sequences and conformations of
AMPs to possibly identify common features that can inform the design of novel short peptides
or small peptide mimetics with antimicrobial potential and a more favorable pharmacokinetic
profile. To this aim, a library of active peptides with known 3D structures was initially created
and clustered and the centroids analyzed. This confirmed the experimental evidence that the majority
of these molecules often contain basic amino acid residues in close proximity to aromatic residues
and that they assume an amphipathic conformation [2,5]. Furthermore, it was shown that their
predicted conformations are in excellent agreement with those experimentally observed in solution.
The structures of the second set of AMPs, with no experimental data about their conformation,
were predicted in silico before being clustered. The judicious analysis of the centroids of the most
populated clusters suggested that these peptides with activity against Gram negative bacteria also
assume amphipathic conformations, although no particular predominance of basic or aromatic amino
acid residues was apparent. Finally, it was demonstrated that the interactions between short AMPs
and a membrane-like environment can be investigated in silico using the predicted structure as a starting
point. The results of this work provide important insights in structural features of AMPs with activity
against Gram negative bacteria and indicate that a combination of in silico approaches can aid efforts
to design novel AMPs.
2. Materials and Methods
2.1. Data Collation
The first dataset of peptides with known 3D structures was created using a search for a string
“antimicrobial peptides” in the protein databank (PDB) [10]. The search results were filtered
to select structures derived from solution-state NMR. All cyclic peptides, dimers or multimers
and peptide-receptor complexes were not considered and no other specific restrictions, e.g., size,
charge, origin or mechanism of action, were included in the search. All peptides were active either
against Gram positive and/or negative strains. A library of 117 PDB entries was thus created based on
results retrieved at the time of the search.
All short peptides were shortlisted from this first set, namely those under 15 residues in length.
This resulted in a list of 12 molecules, which were then further divided into two groups, containing
structures determined either in the presence (Table 1) or absence (Table 2) of micelles.
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Table 1. Sequences of antimicrobial peptides whose 3D structures were determined in the presence
of micelles. For all entries, the NMR data were acquired in the presence of dodecylphosphocholine
(DPC) micelles, with the exception of 2MAA which was obtained in presence of lipopolysaccharide
(LPS) micelles instead.
PDB ID Peptide Sequence AA
2MJT Anoplin [11] GLLKFIKWLL-NH2 11
1G89 Indolicidin [12] ILPWKWPWWPWRR-NH2 13
2F3A LLAA [13] RLFDKIRQVIRKF-NH2 14
1D7N Mastoparan X [14] INLKALAALAKKIL-NH2 15
2JQ2 PW2 [15] HPLKQYWWRPST 12
2JMY CM15 [16] KWKLFKKIGAVLKVL 15
2MAA Temporin-1 Ta [17] FLPLIGRVLSGIL (LPS micelles) 13
1D6X Tritrpticin [18] VRRFPWWWPFLRR 13
1T51 IsCT [19] ILGKIWEGIKSLF-NH2 14
Table 2. Sequences of antimicrobial peptides whose 3D structure has been determined in the absence
of micelles.
PDB ID Peptide Sequence AA
2L24 Not named [20] IFGAIAGFIKNIW-NH2 14
2N9A Decoralin-NH2 [21] SLLSLIRKLIT-NH2 12
2NAL Retro-KR-12 [22] RLFDKIRQVIRK 12
A second set of short cationic antimicrobial peptides was created through a literature
search and cross-referenced against existing on-line databases, such as the “Antimicrobial Peptide
Database” [23]. They were required to be active against Gram negative strains with minimum inhibitory
concentrations (MICs) below 128 µg/mL, have a primary sequence ranging between 9 and 15 amino
acids and carry at least one net positive charge at neutral pH. As opposed to the first set of peptides, no
information about their conformations was available in the literature at the time of the data collation.
2.2. Structure Prediction and Molecular Dynamics Simulation
The 3D conformations of all short peptides from the first set (containing 15 amino acid residues or
fewer) were initially predicted using the online software PEP-FOLD [4]. Due to software limitations,
the conformation can only be predicted for peptides with a primary sequence between 9 and 36
residues. The primary sequence is submitted using a single letter code and the program predicts
the 3D conformation by assembling predicted conformations of short local sequences using a greedy
procedure driven by a coarse-grained energy score. The results were then imported into Maestro as
.pdb files and the C-terminus was amidated when appropriate.
The initial predictions were then submitted to molecular dynamics (MD) simulations using
Desmond [24] and the OPLS 2005 all atoms force field [25] (Maestro version 11.0.014, Schrödinger
LLC, New York, NY, USA). All peptides were prepared for the simulation using Protein Preparation
wizard by adding all hydrogen atoms and setting the protonation states of all ionizable groups for
pH 7. Each peptide was fully solvated using an explicit solvent (SPC water model) with the box size
10 Å larger than the size of the molecule in all directions using System Builder. Ions were added to
mimic physiological conditions with a 0.15 M concentration of NaCl, and including Cl- as counter
ions to neutralize the system. Each system was minimized until the norm of the energy gradient
was <0.1 kcal/mol. Furthermore, the whole system was simulated for 10 ns at 300 K under constant
pressure and temperature (NPT) conditions. The results of the simulations were saved as trajectories
of structures at every 5 ps. Trajectories and structures extracted from the final frame were used for
HC and analysis. Conformations at 0, 1.2 and 10 ns were superimposed on the experimental PDB
structures using the α-carbon alignment tool featured in Maestro.
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The aforementioned method was also applied for the 3D structures prediction of peptides from
the second set, namely by subjecting the PEP-FOLD predicted conformations to 1.2 ns MD simulations
under the same conditions reported earlier.
2.3. Hierarchical Clustering
Hierarchical clustering (HC) was conducted on the two different sets of peptides, with
experimentally-determined and predicted structures. A list of the 3D structures in pdb format was
generated as a text file and submitted to the MaxCluster software for clustering [26]. HC with
average linkage based on root mean square deviation (RMSD) was performed, with a threshold set
at 700 for the first set and 800 for the second. The centroids of the most populated clusters were
analyzed, looking for common features in the amino acid sequences and in the tertiary structures.
The surfaces of all peptides were also generated using the structure analysis tool featured in Maestro
(version 11.0.014, Schrödinger LLC, New York, NY, USA) to evaluate and compare surface hydrophobic
and hydrophilic properties.
2.4. Molecular Dynamics Simulation of Peptides in the Presence of Micelles
Finally, the short antimicrobial peptide Anoplin was selected as a case study for the investigation
of the behavior of short AMPs in presence of a membrane-like environment [27]. The NMR structure
of Anoplin combined with dodecylphosphocholine (DPC) micelle is available as PDB entry 2MJT [11].
In order to test the suitability of this system and of the software used, 2MJT PDB file was initially
downloaded (including the micelle). A fully solvated system was prepared with 10 Å water buffer, 0.15
M NaCl, and Na+ and Cl− as counter ions. A 10 ns MD simulation was conducted using Desmond
and OPLS2005 force field (Maestro version 11.0.014, Schrödinger LLC, New York, NY, USA). This
was followed by a set of MD simulations on a system built to recreate the experimental conditions
described by Uggerhoj [11]. Therefore, a micelle formed by 65 DPC molecules was initially built
using Packmol [28]. The terminal carbon atoms of the hydrophobic chains were constrained in the
center of the box around a sphere of 4 Å radius, so that the hydrophobic tails would point towards
the centre of the micelle. Conversely, all nitrogen atoms belonging to the choline moiety were constrained
around a sphere of radius 18 Å, so that the polar heads of 20 Å long DPC molecules would point towards
the external aqueous environment. A 10-mM phosphate buffer was also included, with three diphosphate
and one monophosphate molecules randomly distributed in the system. Finally, a structure of Anoplin
was also included at a random position 10 Å away from the micelle. Two different systems were built with
Anoplin (1) in an extended conformation and (2) in a conformation predicted using PEP-FOLD. A water
buffer of 80 Å sides was built around the systems using System Builder in Desmond, including 15 mM
NaCl and relevant counter ions. 10 ns simulations were then run using Desmond with the OPLS2005
force field [25], keeping constant atmospheric pressure (1.01325 bar) and room temperature (300 K).
3. Results
3.1. Investigation of a Set of Antimicrobial Peptides with Known Confomation
A set of 117 PDB entries corresponding to NMR-derived conformations of antimicrobial peptides
was created (Table S1). These entries were clustered according to the lowest possible root mean square
difference (RMSD) in an “all vs. all” fashion (Table 3). The four most populated clusters with their
centroids were analyzed in detail, while the structures of the remaining clusters’ centroids are shown
in Figure S1.
The 3D conformations of all peptides containing 15 residues or fewer were then predicted,
by submitting the conformations obtained through the online software PEP-FOLD to 10 ns MD
simulations. The backbones of the conformations simulated at 10, 1.2 and 0 ns (the latter corresponding
to the PEP-FOLD prediction) were superimposed to the corresponding PDB entries, which were
obtained from NMR experiments. The structures were compared using RMSD (Table 4).
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Table 3. Clusters obtained from hierarchical clustering with threshold set at 700.
Cluster Number of AMPs in Cluster RMSD Centroid PDB ID
1 24 417.506 5MMK
2 14 466.125 2MXQ
3 13 270.961 2NDC
4 13 155.284 2RTV
5 11 183.288 5YKL
6 8 626.605 2LG4
7 7 144.665 2MUH
8 7 3.293 2MLU
9 6 500.236 5UI7
10 5 401.027 2MFS
11 3 333.869 1FRY
12 3 666.667 1ZRX
13 2 1.289 2LS1
14 1 0.000 2N0V
Table 4. The root mean square difference (RMSD) values resulting from the superposition of the peptide
α-carbon atoms of the in silico predicted conformations (PEP-FOLD predicted and extracted from
trajectory at 1.2 and 10 ns) on the corresponding experimental determined conformation extracted
from the PDB.
PDB Entry Number of AA RMSD (Å)
PEP-FOLD 1.2 ns 10 ns
2MJT 11 0.4461 0.1793 2.8464
1G89 13 6.4019 6.3364 10.5531
2F3A 14 1.6773 1.4999 1.6041
1D7N 15 2.1988 2.2371 3.1736
2JQ2 12 3.1997 3.5588 3.5946
2JMY 15 1.3061 1.3681 3.0161
2MAA 13 2.0415 2.6618 4.0329
1D6X 13 3.6692 3.3713 4.0437
1T51 14 1.9547 2.4822 2.9325
2L24 14 1.0952 3.0831 5.0254
2N9A 12 1.2719 2.2212 2.6661
2NAL 12 1.3380 1.8398 2.4378
3.2. Investigation of a Set of Antimicrobial Peptides with No Known Conformation
A search for short cationic antimicrobial peptides active against Gram negative strains was
conducted, providing a set of 63 molecules with no experimental available data on their 3D structures
(Table S2). Their initial conformations were predicted using PEP-FOLD, and they were used to build
the systems for 1.2 ns MD simulations. The structures extracted from the final frames of corresponding
trajectories were clustered in an “all vs. all” fashion by calculating the lowest possible RMSD. This
provided 13 clusters, one of which contained 25 peptides and one 20 (Table 5). All other clusters were
only formed by one to three peptides, and the corresponding centroids are shown in Figure S10.
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Table 5. Clusters obtained from hierarchical clustering with threshold set at 800.
Cluster Centroid Size RMSD
1 VCP-VT1 25 321.152
2 UyCT1 20 550.390
3 Andreonicin C1 3 666.667
4 Tigerin3 2 3.302
5 CP-11C 2 500.00
6 Jelleine II 2 500.00
7 Urechistachykinin I 2 0.320
8 Peptide AN5-1 2 0.323
9 Tigerin 1 1 0.000
10 Cn-AMP1 1 0.000
11 Astadidin 2 1 0.000
12 PGLa-H 1 0.000
13 Odirranain-V1 1 0.000
3.3. A System to Study the Interaction of Short Antimicrobial Peptides with a Membrane-Like Structure
A system to study the behaviour of short cationic peptides in presence of a membrane-like
environment, such as dodecylphosphocholine (DPC) micelles, was evaluated. The PDB entry 2MJT
was selected as the template, as it corresponds to the NMR-derived conformation of the antimicrobial
peptide Anoplin in the presence of DPC micelles. Firstly, 10 ns MD simulation on the system was
performed in aqueous buffer to test the suitability of the software. The conditions of the NMR
experiment were then recreated in silico. An MD simulation of a system that included the extended
structure of Anoplin did not result in a folded peptide as expected, as the simulation time of 1.2 ns was
short. In fact, the extended peptide would not provide an adequate interface enabling the formation of
favourable interactions with the micelle. However, when the PEP-FOLD predicted conformation of
the peptide was included in the system, the molecule could be seen embedding into the micelle whilst
assuming the typical amphipathic disposition of the side chains.
4. Discussion
4.1. Investigation of a Set of Antimicrobial Peptides with Known Confomations
A library of 117 antimicrobial peptides (AMPs) with experimentally-known 3D structures was
initially created (Table S1). The corresponding PDB entries were hierarchically clustered through
the MaxCluster software [26]. The distance between two items was calculated on the root mean square
deviation (RMSD), using the Kabsch rotation matrix [29,30]. The software calculates the RMSD by
finding the superposition between two items which gives the lowest score. Average linkage clustering
was selected over single and maximum linkage as it could be less influenced by outliers. In fact,
single linkage is based on the shortest distance between any two members; maximum linkage is based
instead on the largest distance between any two items; whilst average linkage adopts the average of
all pairwise distances between members of the two groups which are being compared. A threshold
was set at 700, aiming to obtain an acceptable number of clusters of peptides with similar folds. These
provided 14 clusters, which are reported in Table 3. The centroids of the four most populated clusters
were analysed in depth.
5MMK is the centroid of cluster 1, which is the most populated one, containing 24 peptides.
It corresponds to the antimicrobial peptide HYL-20, whose sequence is GILSSLWKKLKKII
AK-NH2 [31]. A predominance of the basic amino acid lysine can be observed. It should be noted
that Lys8 in particular is positioned next to the aromatic amino acid Trp7. 5MMK assumes an α-helix
secondary structure (Figure 1b). It was observed that 19 members out of 24 in this cluster also
assume at least a partial α-helix conformation (Figure 1a). Hydrophobic and hydrophilic regions
of the 5MMK surfaces were calculated with Maestro (version 11.0.014, Schrödinger LLC, New York,
Pharmaceutics 2018, 10, 72 7 of 25
NY, USA) and it can be observed that the hydrophilic and hydrophobic side chains are clustered on
the two opposite sides of the protein, with a predominance of the hydrophilic portion, which can be
attributed to the positively-charged amino acids (Figure 1c). 5MMK therefore assumes an amphipathic
configuration, as expected [32].
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Figure 1. (a) Superimposition of all members of cluster 1 onto the backbone of the centroid
5MMK shown in thick blue trace representation. 19 members out of 24 in this cluster assume
at least a partial α-helix conformation (thin, coloured α-carbon traces); (b) Stick representation of
the experimentally-derived conformation of 5MMK. The ribbon shows how the antimicrobial peptide
5MMK assumes an α-helix conformation; (c). Side view of the PDB entry 5MMK, highlighting the polar
regions of the surface. The hydrophilic part is shown in cyan, whilst the hydrophobic component is
displayed in amber.
2MXQ was also investigated, being the centroid of the second most populated cluster, which
includes 14 peptides (Table 3). It corresponds to DEFA1, a 34-amino-acid peptide, whose sequence
is SCTCRRAWICRWGERHSGKCID9KGSTYRLCCRR [33]. DEFA1 has a rather longer sequence if
compared to the first centroid analysed. However, a predominance of basic amino acid residues,
in this case arginine, can still be observed, which in several cases are close to either another arginine
(Arg5-Arg6, and Arg33-Arg34), or next to an aromatic amino acid, such as tryptophan, histidine or
tyrosin (Arg11-Trp12, Arg15-Trp16, Tyr28-Arg29). In c ntrast with HYL-20, it does not a sume an
α-helix a defin te conformation in solutio , possibly sugges ing a flexible peptide (Figure 2b) [33].
Despite this, the majority of the members belonging to cluster 2 (11 out of 14) adopt a β-sheet
conformation in a part of their sequence, in clear contrast with cluster 1 previously investigated
(Figure 2a). The investigation of the polarity of the surface also showed no clear predominance of one
region over the other. However, a separation between the two can still be seen, with the hydrophobic
portion appearing “sandwiched” between two hydrophilic areas, suggesting an amphipathic nature of
the peptide (Figure 2c).
2RTV is the centroid of cluster 3, which contains 13 peptides (Table 3). It corresponds to
the NMR-derived structure of the p ptide Tachyplesin I in water [34]. I is a C-termin lly amidated
18-residu peptide, whose equence is KWCFRVCYRGICYRRCR-NH2. It can be observed that it is also
rich in basic amino acids, which are responsible for the overall positive charge of the peptide at neutral
pH, with 5 arginine and one lysine residues. It can also be noted that these residues are always close
to an aromatic residues, such as tryptophan, tyrosine or phenylalanine, with the exception of Arg15,
which is however next to another Arg residue, and the terminal Arg18. 2RTV forms two β-sheets
connected by a loop (Tyr8, Arg9, Gly10, Ile11) and linked together by two disulfide bridges (Cys16-Cys3
and Cys12-Cys17) (Figure 3b). The majority of the members of this cluster also assume a β-sheet
conformation (Figure 3a). Although less evident than for 5MMK, here again two distinct regions
can be identified: a hydrophilic portion is formed by the N-terminal Lys and C-terminal Arg and at
the loop around Arg9 (Figure 3c), whilst a hydrophobic section is found around the β-sheet between
Tyr8 and Trp2 (Figure 3d).
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Figure 2. (a) Superimposition of all me bers of cluster 2 onto the back one of the centroid 2MXQ (thick
blue trace). The majority of the members of this cluster assume a parti l β-sheet configuration, with
only 2K35, 2MMM, 2MN5 and 2N8D including α-helix regions; (b) Stick and ribbon representations of
the experimentally-derived conformation of 2MXQ which does not assume a definite conformation; (c)
PDB structure 2 XQ, corresponding the defensin-like peptide EF 1 is here shown. The hydrophilic
region of the olecule surface is coloured in cyan, whilst the hydrophobic portion is shown in amber.
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Figure 3. (a) Peptides populating cluster 3 superimposed onto the back one of the centroid 2RTV (thick
blue trace). No member of this c hort presented an α-helix arrangement; (b) Experimentally-derived
3D conformation of the centroid 2RTV; (c) The hydrophobic (amber) and hydrophilic (blue) regions
on the urface of 2RTV are shown. It can be observed that Tachyplesin I displays a predomin ntly
hydroph lic nature; (d) Detail of the hydrophobic region.
ti is t c tr i f cl st r ic ls c t i s ti s ( l ). Its
s ce is IL , ich a ain is c racterized by t e r s ce f sic r
s r si s [ ]. In articular, s c f ext t r atic r s is t t
r tic r . It ss s rti ll - lic l s c r str ct r , li t j rit f t rs
f t is cl st r ( i r , ). s r risingly, its s rf c is ls l r l r ilic ( i r c). is
ti is lic l i t i l f t s c .
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Figure 4. (a) Members of cluster 4 are shown superim osed t the centroid 2NDC (thick blue trace).
9 members out of 13 also assume at least a partial α-helical conformation; (b) Experimentally-derived
conformation of peptide 2NDC; (c) PDB entry 2NDC with its surface investigated. Hydrophobic areas
are shown in amber, hydrophilic in cyan.
Most of the NMR-derived conformations of centroids of the remaining clusters feature secondary
structures observed in the first four clusters, i.e., α-helixes (Figure S1b,d,h) and β-sh ets (Figure S1c,f,i),
while the rest adopt less ordered structures. Despite having distinct features resen in the centroids
of clust rs 1 to 4, the memb rs of remaini g clusters do not group wit those clust rs due to either
the presence of disulfide bonds (i.e., PDB entry 2MUH) or their larger size, which may lead to
difficulty in ab initio prediction of their structure, as it is less reliable than the prediction of the shorter
sequences [35].
4.2. Evaluation of In Silico Appraoches to Predict Conformation of Short Cationic Peptides
All peptides with known structure and with sequence length under 15 residues were shortlisted for
further analysis. Their conformations were initially predicted with the online software PEP-FOLD and then
submitted to 10 ns MD simulation in an aqueous buffer. The PEP-FOLD predictions (corresponding to
0 ns conformation), as well as the conformations at 1.2 and 10 ns of the si ulation were superimposed
onto he expe imental PDB entry in order to investigate the quality of such predictions and stability
of predicted structures. It can be observed that the PEP-FOLD conformations, which correspond to
the starting point of the MD simulation, are generally in good agreement with experimentally-determined
structures extracted from PDB entries as suggested by RMSD values (Table 4).
The best agreement between predicted and experimental conformations was observed for
the peptide corresponding to the PDB entry 2MJT, with the best superposition given by the PEP-FOLD
prediction (RMSD = 0.4461 Å), which is in line with the previously observed performance of PEP-FOLD
software [36]. It is not only that the backbones are aligned, but most of the side-chains too. (Figure 5,
0 ns). A sim lar performance was observed for other helical AMPs (2F3A, 1D7N, 2JMY, 2MAA, 1T51,
2L24, 2N9A and 2NAL), with the helical part f the backbone aligned while the termini show flexibility
(Figures S2–S9).
It is important to note that PEP-FOLD predicts the conformation of peptides in an aqueous
environment. The experimental structures of 2MJT, 1G89, 2F3A, 1D7N, 2JQ2, 2JMY, 2MAA, 1D6X
and 1T51 were determined in the presence of micelles, believed to induce the formation of an
amphipathic surface. To establish if the predicted structures are stable in water without micelles,
we have conducted MD simulations of all peptides under physiological conditions. Although
the RMSD decreases over simulation time in most cases, possibly indicating a flexible peptide, most
of the abovementioned p p ides preserve secondary structure (Figure 5 and Figures S2–S9). This
suggests that the predicted structur s are stable for at least 1.2 ns of simulation despite the absence
of the membrane. The PEP-FOLD predicted conformations do not fully unfold in an aqueous
environment and the secondary structure is preserved during the simulation in a fully solvated system
but without a membrane environment. Therefore, a short simulation of 1.2 ns without the membrane
could be used to explore the dynamic nature of AMPs (Table 4).
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Similar behaviour is observed for the peptide corresponding to the PDB entry 2JQ2, for which 
the α-helix content was overestimated (Figure 7), as well as PDB entry 2MAA (Figure S5). It was 
observed that the simulation relaxed the structure into a conformation with a higher RMSD, but some 
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There was only one peptide in the set of the short peptides that did not have helical structure, 
which was extracted from the PDB entry 1G89. It assumes a “U” shape with rather flexible ends (a 
range of RMSD for the experimentally-determined structures was from 0.6 to 1.9 Å). The absence of 
the micelle and absence of intramolecular interactions due to the intrinsic nature of the peptide led 
to a much higher RMSD between the predicted and experimental structures (RMSD = 6.4 Å). 
However, it can be observed that the central part of the peptide sequence (hydrophobic and possibly 
responsible for driving bioactive conformation) overlaps better than the termini (Figure 8). 
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This is particularly true for the peptide corresponding to the PDB entry 1D6X, which had 19
N R-based conformations stored in the downloaded file. The R SD between the lowest energy
structure and the rest of the set was in the range from 1.4 to 2.25 Å, suggesting that the peptide itself is
flexible in presence of micelles. Despite that flexibility, the predicted structure has key features similar
to the experimental structure that are mainly preserved during simulation (Figure 6).
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. Backbone superposition of PDB entry 1D6X (re ) and simulated conf rm tions at 0,
.2 and 10 ns (blue). No significant change was observed over the simula ion time, with a sligh
improvement at 1.2 ns.
Similar behaviour is observed for the peptide corresponding to the PDB entry 2JQ2, for which
the α-helix content was overestimated (Figure 7), as well as PDB e try 2MAA (Figure S5). It was
observed that the simulation relaxed the structure i to a confor ation with a higher RMSD, but some
of the key features became similar to the experimentally-determined conformation.
There was only one peptide in the set of the short peptides that did not have helical structure,
which was extracted from the PDB entry 1G89. It assumes a “U” shape with rather flexible e ds (a
range of RMSD for the experimentally-determined structures was from 0.6 to 1.9 Å). The absence of
the micelle and absence of intramolecular interactions due to the i trinsic nature of the peptide led
to a much higher RMSD between the predicted and experimental str ctures (RMSD = 6.4 Å). However,
it can be observed that the central part of the peptide sequence (hydrophobic and possibly responsible
for driving bioactive conformation) overlaps better than the termini (Figure 8).
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for forming an α helix. 
4.3. Common Structural Features of Antimicrobial Peptides with Activity against Gram Negative Bacteria 
Based on these observations, the 3D structures of 63 short cationic antimicrobial peptides with 
no known 3D structure were predicted by submitting the PEP-FOLD-obtained conformations to 1.2 
ns MD simulation. It was chosen to only consider short peptides in anticipation of an improved 
pharmacokinetic profile and driving drug like properties during the design of novel molecules. The 
resulting conformations were once again clustered using the MaxCluster command and the resulting 
clusters were analysed for common features [26]. 
Peptide VCP-VT1 is the centroid of the most populated cluster, which contains 25 peptides 
(Table 5). Its sequence is FLPIIGKLLSGLL. It only contains one aromatic amino acid residue (Phe1), and 
one basic residue (Lys7) and it maintains an α-helical conformation after 1.2 ns MD simulation, like the 
majority of the members of this cluster (Figure 9a,b). All peptides in cluster 1 were also superimposed 
along the α-carbon atoms using the superposition tool featured in Maestro. The residues were colored 
according to their properties. A predominance of hydrophobic and electrostatically positively-charged 
residues was observed. Interestingly, a clear separation in the disposition of the two sets of residues 
was noted, with all the positively-charged side chains converging towards one side of the peptide 
(Figure 9c). This observation complies with the hypothesis that these peptides assume an 
amphipathic 3D conformation [2], with a charged region responsible for binding to the negatively-
charged LPS on the surface of Gram negative bacteria, and a predominantly hydrophobic nature 
Figure 7. Backbone superpositio of B entry 2JQ2 (red) and simulated conformations at 0, 1.2
and 10 ns (blue). NMR experiments show that 2JQ2 assumes relaxed coiled conformations, whilst
the PEP-FOLD prediction provides a partially α-helical structure, which progressively deteriorates
over the simulation time.
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Figure 8. Backbone superposition of PDB entry 1G89 (red) and conformations at 0, 1.2 and 10 ns of MD
simulation (blue).
These r sults indicate that, despite the absence of a membrane-like envir nm nt, PEP-FOLD
complemented with molecular dynamics simulation of 1.2 ns can be used for pr dicting AMP structure
and to explore the dynamics nature of these peptides, especially those that have propensity for forming
an α helix.
4.3. Common Structural Features of Antimicrobial Peptides with Activity against Gram Negative Bacteria
Based on these observations, the 3D structures of 63 short cationic antimicrobial peptides
with no known 3D structure were predicted by submitting the PEP-FOLD-obtained conformations
to 1.2 ns MD simulation. It was chosen to only consider short peptides in anticipation of an
improved pharmacoki etic pr fil and driving drug lik properties during the esign of novel
molecule . Th resulting confor ations w re once again clustered using the MaxCluster command
and the resulting clusters wer analysed for co mon features [26].
Peptide VCP-VT1 is the centroid of the most populated cluster, which contains 25 pepti es
(Tabl 5). Its seq nce is FLPIIGKLLSGLL. It only contains one aromatic amino acid residue (P 1),
and one basic residue (Lys7) and it maintains an α-helical conformation after 1.2 ns MD si ulation,
like the majority of the members of this cluster (Figure 9a,b). All peptides in cluster 1 were also
superimposed along the α-carbon atoms using the superposition tool featured in Maestro. The residues
were colored according to their properties. A predominance of hydrophobic and electrostatically
positively-charged residues was observed. Interestingly, a clear separation in the disposition of
the two sets of residues was noted, i ll the positively-charged side chains convergin towards
one side of the peptide (Figure 9c). This observation complies with the hypothesis that th se
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peptides assume an amphipathic 3D conformation [2], with a charged region responsible for binding
to the negatively-charged LPS on the surface of Gram negative bacteria, and a predominantly
hydrophobic nature allowing the peptide to then penetrate the membrane. The surface of the centroid
VCP-VT1 was also analysed in terms of polarity, and a clear distinction between hydrophilic
and hydrophobic areas could be observed (Figure 9d), in accordance with what was discussed for
the peptides with experimentally-known conformations.
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cluster 2 (Figure 10a). The disposition of the residues was also analysed and a clear separation 
between hydrophobic amino acids and positively-charged residues can be observed once again 
(Figure 10c), in accordance with what previously observed for cluster 1 (Figure 9c). This is mirrored 
by the analysis of the surface of the centroid UyCT1. A clear distinction between hydrophobic and 
hydrophilic areas can be seen (Figure 10d), once again confirming what observed for the first set of 
antimicrobial peptides with experimentally-derived conformations. 
The centroids of less populated clusters have less ordered structures (Figure S10), but in most 
cases form surfaces with amphipathic nature, those sequences can be also used as a starting point for 
a design of molecules with novel architectures, but the detailed analysis of structures are beyond this 
work. 
Fig re 9. (a) Backbone superposition of all members of cluster 1 onto the centroid VCP-VT1 (thick blue
trace); (b) Predicted conformation of VCP-VT1 after 1.2 ns MD simulation; (c) The peptides belonging to
cluster 6 are shown superimposed and the residues re colour d according to their electrical properti s:
hydrophobic residues in green, positively-charged in blue, polar uncharged i cyan. A few peptides also
ontain n gatively-charged residues (red), however the overall charge of th molecule is still positive.
Two distinct areas can be observed, with a positively-charged portion and a predominant hydro hobic
or uncharged region; ( ) The surface of the c nt oid CVP-V 1 i shown along the N-terminal side,
with hydrophilic areas in cyan and hydrophilic regions in amber. A clear istinction can be observ d
between the two.
Cluster 2, which contains 20 peptides, was also investigated. Its centroid is peptide UyCT1 [37],
whose sequence is GFWGKLWEGVKNAI-NH2. It is a predominantly hydrophobic peptide, with
three aromatic amino acid residues (Phe2, Trp3 and Trp7) and two positively-charged residues (Lys5
and Lys11). It assumes an α-helical conformation after PEP-FOLD prediction, which is maintained
during MD simulation (Figure 10b). The same can be said for the majority of the peptides forming
cluster 2 (Figure 10a). The disposition of the residues was also analysed and a clear separation between
hydrophobic amino acids and positively-charged residues can be observed once again (Figure 10c),
in accordance with what previously observed for cluster 1 (Figure 9c). This is mirrored by the analysis
of the surface of the centroid UyCT1. A clear distinction between hydrophobic and hydrophilic areas
can be seen (Figure 10d), once again confirming what observed for the first set of antimicrobial peptides
with experimentally-derived conformations.
The centroids of less populated clusters have less ordered structures (Figure S10), but in most
cases form surfaces with amphipathic nature, those sequences can be also used as a starting point
for a design of molecules with novel architectures, but the detailed analysis of structures are beyond
this work.
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Anoplin, a 12-residue C-terminally amidated peptide, has been shown to exert its antimicrobial 
activity through ion channel-like activity in a membrane-like environment [38]. It was shown that 
this system remains stable after 10 ns MD simulation, as the micelle does not disassemble and 
Anoplin remains embedded onto its surface, maintaining the characteristic amphipathic structure 
(Figure 11a–d). 
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NMR experiment had been conducted [11]. The same MD protocol was therefore applied to an 
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Figure . (a) The members of cluster 2 are shown superimposed to the centroid UyCT1
(thick blue trace); (b) Predicted conformation of UyCT1; (c) Side view of the pept des forming
cluster 2 superimp sed along the α-carbon. A colour scheme was applied according to residue
properties: hydrop obic residues in gree , positively-charged i blue, polar uncharged in cyan
and negatively-charged in red. A clear separation between the two regions can be seen (d) The surface of
the centroid UyCt1 is shown along the C-termi al side, wit hydrophilic areas in cyan and hydrophobic
regions in amber.
4.4. MD Simulation to Evaluate Interaction of Short Antimicrobial Peptides with a Membrane-Like Structure
The of MD simulations for the study of t e behaviour of these c tionic antimicrobial
peptides in th presence of membrane-like structures was evaluated. With respect to this, a y
NMR experiments use solutions of the p ptide in th presence of micelles of amphipat ic molecules,
whose rol is to mimic the membrane. The PDB entry 2MJT, which correspon s to the NMR-derived
conformat on of the an microbia peptide Anoplin in the pr sence of d decylphosphocholine (DPC)
mic ll s, was selected as a m del syst m to validate our molecular dynamics simulations setup [11].
Anoplin, a 12-residue C-terminal y amidated peptide, has been shown to exert its antimicrobial
activity t r l-li activity in a membrane-lik environment [38]. It was shown
that thi system remains stable after 10 ns MD simulation, as the micelle does not disassemble
and Anoplin remains embed ed onto it surface, maintaining the characteri ti i structure
(Figure 1 a–d).
The next step was to design a i s lico system reproducing the same conditio s in which the NMR
experiment had been conducted [11]. The same MD protocol was therefore applied to n artificially
built system, containing the micelle, the xtended peptide built from scratch and the phosphate buffer.
However, no int racti n between the peptide and the micell was observed at the nd of the simulation,
nor did peptide seem to be able to adopt an amphipathic c nformation (Figure 12).
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Figure 11. (a) I fra e of the MD simulati n of the PDB entry 2MJT; (b) Anoplin mbedded
in the micelle at the beginning of the MD simulations; (c) Final frame of the MD simulations;
(d) Anoplin remains embedded into the micelle at the end of t e simulation, showing that this
system is stable under the conditions used. The residues have been coloured according to their
properties, with positively-charged amino acids in blue, hydrophobic in green, neutral in grey and polar
uncharged in cyan. It can be observed that Anoplin maintains an amphipathic conformation throughout
the simulation.
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Figure 12. Conformation of extende li at t e e d of 10 ns si lation. The residues are
col ured according to their properties, it l t t ticall siti l -charged amino acids in blue,
hydrophobic n green, polar uncharged in cya l in r . observed tha the eptide
does not assume an mphipathic confor ati .
The simulation was then repeated under the same conditions but using the PEP-FOLD predicted
3D conformation of Anoplin. This time, a clear interaction between micelle and the peptide was
observed, with the latter clearly embedding into the membrane-like surface after assuming an
amphipathic conformation (Figure 13a–d).
This is consistent with the previously-observed inability of MD simulations to predict the correct
fold from an extended structure even at time-costly simulations of 2 µs. Those long simulations
(CPU time) of even relatively small systems comprising peptide, micelle and water molecules are
impractical for most academic and industrial groups mainly due to duration (real time) and available
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computational resources. Therefore, having a realistic starting structure can reduce the need to
predict folding of the peptide and significantly decrease the duration of simulations. Here, we have
found that PEP-FOLD can predict the fold of AMP that can occur in membrane-like environments,
but other methods, not tested here, can be also validated for this use, i.e., PEPstrMOD [39],
simulated tempering [40], multiple simulated annealing-molecular dynamics [41] or FlexPepDock [42].
Once the methods are validated, studies can be extended to molecular dynamics simulations
of a peptide in the presence of lipopolysaccharide (LPS) micelles, which could provide a more relevant
representation of the interactions between the peptide and a surface of a Gram negative bacterium [43].
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Figure 13. (a) Initial frame of the MD simulation on a syste i P-FOLD predicted 3D
struct re of Anoplin; (b) Initial frame of the simulation, sho i t redicted conformation
of Anoplin posit oned away from the surface of th micelle; (c) Final frame of the simulation;
(d) Final frame of the simulatio , showing Anoplin embedded into the surface of the icelle in an
amphipathic conformation. Resid s are coloured according to t e surface, with positively-charged
amino acids in blue, hydrophobic in green, polar uncharged in cyan and neutral in grey.
5. Conclusions
The structures and conformations of two sets of cationic antimicrobial peptides were clustered
and compared. Importantly, the predicted conformations of AMP were in a good agreement with
those determined experimentally, although the presence of a membrane was not explicitly taken
into consideration. Consequently, the peptides acting against Gram negative bacteria had their
conformations predicted through the online software PEP-FOLD and then submitted to molecular
dynamics simulations before being clustered to identify common features possibly responsible for their
activity. Significantly, the analysis of the most-populated clusters confirmed that these peptides tend to
assume an amphipathic conformation, which is in accordance with their suggested mechanism of action.
It was also observed that the majority of these peptide oft n contain basic mi o acids in proximity to
aromatic residues. Fi ally, it was demonstrated that MD simulatio s in ombinati n with prediction
of the initi l conformation can be used to study t e interaction of short AMPs with a membrane-like
structure s ch as dodecylp osphocholine (DPC) micelles. The results of this study su cessfully
demonstrate that a c mbinatio of in silico approaches ca be utilized to identify common structural
features of AMPs and inform the rational design of novel antimicrobial agents.
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Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4923/10/3/
72/s1, Table S1: Set of antimicrobial peptides with known 3D structures derived from NMR experiments,
Table S2: Set of short sequence antimicrobial peptides, showing their size, sequence, net charge at pH 7.4
and minimum inhibitory concentration (MIC) against some of the most common Gram-negative strains, Figure S1:
The experimentally-derived conformations of the PDB entries the centroids of the less populated clusters resulting
from hierarchical clustering (HC) of 117 antimicrobial peptides with experimentally-known conformations,
Figure S2: Backbone superposition of PDB entry 2F3A (red), with simulated conformations at 0, 1.2 and 10 ns (blue).
The conformation at 1.2 ns is very similar to the PDB entry and it progressively modifies during the simulation.,
Figure S3: Backbone superposition of PDB entry 1D7N (red) with simulated conformations at 0, 1.2 and 10 ns (blue).
Superposition slightly decreases over simulation time, suggesting a flexible peptide, especially at the extremities,
Figure S4: Backbone superposition of PDB entry 2JMY (red) with simulated conformations at 0, 1.2 and 10 ns (blue).
RMS at 0 and 1.2 are quite similar, but similarity decreases over simulation time, suggesting flexibility, especially
at the N terminus, Figure S5: Backbone superposition of PDB entry 2MAA (red) and simulated conformations at 0,
1.2 and 10 ns (blue). RMS progressively increases during simulation time, Figure S6: Backbone superposition of
PDB entry 1T51 (red) and simulated conformations at 0, 1.2 and 10 ns (blue). Similarity decreases over simulation
time, with a distinct flexibility observed at the C terminus, Figure S7: Backbone superposition of PDB entry 2L24
(red) and simulated conformations at 0, 1.2 and 10 ns (blue). As opposed to the peptides analyzed previously,
the NMR experiments of 2L24 were acquired in the absence of micelles. However, similarly to the previous
cases, similarity also decreases over simulation time, Figure S8: Backbone superposition of PDB entry 2N9A (red)
and simulated conformations at 0, 1.2 and 10 ns (blue). 2N9A NMR data were obtained in a simple solution
without micelles. Similarity decreases over simulation time, Figure S9: Backbone superposition of PDB entry 2NAL
(red) and simulated conformations at 0, 1.2 and 10 ns (blue). NMR data were obtained in the absence of micelles
and similarity decreases over simulation time, Figure S10: The conformations centroids of the less populated
clusters after hierarchical clustering of the predicted structures of cationic peptides with activity against Gram
negative bacteria. References [11,12,14–16,18–22,31,33,34,37,44–173] are cited in the supplementary materials
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